Ajax-Loading

Roche Holding AG - Stock Based Compensation

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "Stock-Based-Compensation" stands at 0.196 Billion Swiss Francs for the trailing twelve months (TTM) period ending 03/31/2026, the lowest value at least since 12/31/2012, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -77.08 percent compared to the value the year prior.
The 1 year change in percent is -77.08.
The 3 year change in percent is -82.67.
The 5 year change in percent is -72.51.
The 10 year change in percent is -51.36.

The Serie's long term average value is 0.584 Billion Swiss Francs. It's latest available value, on 03/31/2026, is 66.45 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2025, to it's latest available value, on 03/31/2026, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 03/31/2026, is -82.67%.

Stock Based Compensation for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Stock Based Compensation905,699,262,464.00
LogoJohnson & Johnson - Stock Based Compensation486,508,953,600.00
LogoAbbVie Inc - Stock Based Compensation399,570,305,024.00
LogoAstraZeneca PLC - Stock Based Compensation280,205,508,085.11
LogoNovartis AG - Stock Based Compensation255,096,620,580.91